Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.
The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.
India’s Semiconductor Strategy: Redefining the Global Tech Race
Who Is Arvid Lindblad? Rising Young Racer Of Indian Origin All Set For F1 Debut With Racing Bulls In 2026 Season
Sensex Skids 156.83 Points To 84,949.98, Nifty 47
Internet Subscribers In India Rise 1.49% To 1,017.81 Million In Q2: TRAI Data
